منابع مشابه
A case of drug-induced hepatic injury associated with sitagliptin.
A 58-year-old man with a 10-year history of type II diabetes mellitus presented with progressive jaundice that began three days before admission. Thorough history-taking revealed that the patient had started on a new medication, sitagliptin, one month previously for the treatment of diabetes mellitus. Laboratory investigations showed severe liver dysfunction. Ultrasonography detected no extrahe...
متن کامل[Drug-induced hepatic injury, the challenge for cause investigation].
This report is the story of the long journey to identify the mechanism of fulminant hepatitis by the antigout drug, Benzbromarone. As soon as the 8th gout patient prescribed Benzbromarone (Benz) died of fulminant hepatitis in 20 years, the letter was sent to doctors identifying it as the causative agent in February 2000. At that time, Benz had been prescribed to 350,000 patients/year for 20 yea...
متن کاملdrug induced liver injury: a review article
the incidence of drug induced liver injury (dili) is about 1/1000 to 1/10000 among patients who receive therapeutic drug doses. drug induced hepatotoxicity is a major cause of acute and chronic liver disease. the severity of liver damage ranges from nonspecific changes in liver structure to acute liver failure, cirrhosis and liver cancer. some common agents that can cause liver injury are aceta...
متن کاملDrug-induced oesophageal injury.
'Blackett, R L, et al, British Journal of Surgery, 1978, 65, 393. 2 Wilmore, D W, and Dudrick, S J, Archives of Surgery, 1969, 98, 256. 3 Durskin, M S, and Seigal, P D, 7ournal of the American Medical Association, 1963, 185, 966. 'Copeland, F M, et al, Surgery, Gynecology, and Obstetrics, 1974, 138, 377. 6Horshal, V L, Ause, R G, and Hoskins, P A, Archives of Surgery, 1971, 102, 353. Tanner, W ...
متن کاملDrug-induced liver injury.
Drug-induced liver injury is a frequent cause of hepatic dysfunction. Reliably establishing whether the liver disease was caused by a drug requires the exclusion of other plausible causes and the search for a clinical drug signature. The drug signature consists of the pattern of liver test abnormality, the duration of latency to symptomatic presentation, the presence or absence of immune-mediat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 1982
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.71.568